Comprehensive newborn screening
Ended Purchase Order Awarded Last action
- Contract number
- W91YU014P0248
- Awardee
-
Revvity Omics Inc. UEI LDJULX8K6M85 Part of Revvity Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $375,186
Award facts
- Opportunity
-
- Maintenace and Repair of Stryker Scopes Services Award Notice · Posted Apr 2, 2014
- Non-Personal Service Comprehensive Newborn Screening Testing. Award Notice · Posted Mar 24, 2014
- Contract value 100% obligated
- $375,186.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bridgeville, PA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$3,822 | |
| Terminate for Convenience | -$16,632 | |
| Supplemental Agreement for work within scope | $16,800 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $105,000 | |
| Exercise an Option | $0 | |
| Funding Only Action | $136,920 | |
| Change Order | $31,920 | |
| Exercise an Option | $0 | |
| Original award | $105,000 |
About this award
This firm fixed-price purchase order contract was awarded by the Department of the Army Medical Command to Revvity Omics Inc., doing business as Perkinelmer Genetics, for comprehensive newborn screening services. The contract has a potential value of $375,186.00 and a completion date of September 30, 2016.
Perkinelmer Genetics, a for-profit subsidiary of Revvity Inc., specializes in medical imaging and genetic testing services. This contract supports the military healthcare system by providing newborn screening for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis at military treatment facilities and hospitals, including locations overseas. Perkinelmer Genetics performs the testing at its own laboratories and does not appear to rely on major subcontractors. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract W91YU014P0248?
W91YU014P0248 was awarded to Revvity Omics Inc. by Medical Command (Department of the Army) on April 23, 2014.
How much is contract W91YU014P0248 worth?
The government has obligated $375,186 on W91YU014P0248.
Was contract W91YU014P0248 competed?
The extent of competition for W91YU014P0248 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award